This week's innovators to know roundup includes Patrick Jankowski of the Greater Houston Partnership, Deanea LeFlore of The Ion, and Dr. Mehdi Razavi of the Texas Heart Institute. Photos courtesy

Editor's note: In this week's Monday roundup of Houston innovators, I'm introducing you to three innovators across the city — from the Greater Houston Partnership, The Ion, and Texas Heart Institute.

Patrick Jankowski, senior vice president of research

The Greater Houston Partnership hosted its annual economic outlook event online this week. Photo courtesy of the GHP

At the GHP's annual economic outlook, Patrick Jankowski, senior vice president of research, predicts that 2021 will be a "bipolar year." The first and second halves of the year are going to look different, Jankowski says, it's just a matter of how different at this point. In addition to the vaccine and COVID case numbers, the things the GHP as well as Houston businesses are watching is the new Biden Administration.

"We won't see any significant growth in the economy until we get to the second half of the year," he says. Read more.

Deanea LeFlore, director of partnerships at The Ion

Deanea LeFlore, director of partnerships at The Ion, joins this week's episode of the Houston Innovators Podcast. Photo courtesy of Station Houston

Houston is just a few months away from being able to walk into The Ion, and the organization's director of partnerships, Deanea LeFlore, hopes that when that happens, they are entering a innovation hub reflective of the city.

"I think that when people walk into The Ion, what's personally important to me, is that it looks like Houston so that you see yourself reflected in the people in the building as well as the programming," LeFlore says. "That's my biggest hope and aspiration, and I believe we are well on track to be able to deliver on exactly that."

LeFlore shares more on what she's been working on — from online programming to growing partnerships at The Ion. Listen to the podcast and read more.

Dr. Mehdi Razavi, director of Electrophysiology Clinical Research & Innovations at the Texas Heart Institute

A medical device coming out of the Texas Heart Institute has been recognized for its innovation. Photo via THI

A new technology out of Houston's Texas Heart Institute's was named the top future medical product design worldwide last month as part of the annual Create the Future Design contest. The med device, which allows for pain-free defibrillation, is being developed by THI's Electrophysiology Clinical Research & Innovations team in conjunction with scientists at Rice University and UCLA, the technology allows doctors to place up to 12 tiny nodes around the heart to pace and defibrillate the heart without using a shock.

The technology will be most useful for atrial fibrillation and ventricular fibrillation, which can lead to sudden death, stroke, and congestive heart failure, according to Dr. Mehdi Razavi, the head investigator on this project and leader of the THI team.

"It's extremely painful. It's like someone takes a two by four and just pounds you from the inside in the chest, or a horse kicking you in the chest," Razavi says. He went on to add: "I have actually one patient who was a Vietnam veteran. He said nothing that he faced in battle was as disconcerting—not just because of the pain, but the fact that you don't know when the pain is when the shock is about to happen. That anxiety is just overwhelming." Read more.

A medical device coming out of the Texas Heart Institute has been recognized for its innovation. Photo via THI

Houston innovation team wins global award for painless heart technology

heart of gold

Houston's Texas Heart Institute's pain-free defibrillation technology was named the top future medical product design worldwide last month as part of the annual Create the Future Design contest.

The tiny technology aims to change the way cardiac arrhythmias are managed and remove the often traumatizing pain associated with their treatment. Developed by THI's Electrophysiology Clinical Research & Innovations team in conjunction with scientists at Rice University and UCLA, the technology allows doctors to place up to 12 tiny nodes around the heart to pace and defibrillate the heart without using a shock.

The technology will be most useful for atrial fibrillation and ventricular fibrillation, which can lead to sudden death, stroke, and congestive heart failure, according to Dr. Mehdi Razavi, the head investigator on this project and leader of the THI team. Razavi says winning the award "speaks to the need" of a new solution in the field as the shocks associated with traditional implantable cardioverter-defibrillators, or ICDs, can cause severe PTSD among patients.

"It's extremely painful. It's like someone takes a two by four and just pounds you from the inside in the chest, or a horse kicking you in the chest," Razavi says. He went on to add: "I have actually one patient who was a Vietnam veteran. He said nothing that he faced in battle was as disconcerting—not just because of the pain, but the fact that you don't know when the pain is when the shock is about to happen. That anxiety is just overwhelming."

Instead of shocking the patient's heart in a central location, the nodes spread energy needed to pace the heart at the correct rate throughout the muscle based on their location. This dilutes the feeling of a sudden jolt, and Razavi says, defibrillation using his technology could go unnoticed in patients.

In addition to this game-changing possibility, the new technology is physically safer in many ways, too. The miniaturized battery-less pacing system is free of traditional wires that send electrical pulses to the heart, known as leads. These leads can dislodge and fracture within the body and can cause infection.

The technology's wireless and miniature nature also allows doctors to better access regions of the heart that currently are difficult to reach with bulkier ICDs. Each node can be individually programmed and can stimulate different regions of the heart in different ways, as well.

A cross disciplinary team developed the device. Aydin Babakhani, an associate professor in physical and wave electronics at UCLA first developed the nodes to stimulate electricity for non-medical purposes. Behnaam Aazhang, the J.S. Abercrombie Professor of Electrical and Computer Engineering and the Director of the Rice Neuroengineering Initiative, first introduced Razavi to Babakhani, and the trio worked together to bring the technology to the medical arena, along with about 15 to 20 other medical professionals and students.

The team at Rice is continuing to develop the hardware for clinical use. And studies on the use of defibrillation through these nodes across the heart are being conducted out to the Texas Heart Institute's research lab. Razavi and his team are currently conducting preclinical studies on the new form of treatment and aims to roll it out for clinical use in the next three to five years.

From Houston inventors being recognized to Chevron's latest investment, here's what innovation news you need to know. Photo by Dwight C. Andrews/Greater Houston Convention and Visitors Bureau

Chevron makes another investment, Houston researchers nationally recognized, and more innovation news

Short Stories

Houston's innovation news hasn't quite slowed yet for the holidays. This most recent news roundup includes lots of money raised, a new contract for a Houston startup, innovators recognized and more.

For more daily innovation news, subscribe to InnovationMap's newsletter, which goes out every weekday at 7 am.

Chevron Technology Ventures invests in Texas company

Courtesy of CTV

Houston-based Chevron Technology Ventures has contributed to Austin-based motor tech company Infinitum Electric's $12.5 million Series B round of financing. New Mexico-based Cottonwood Technology Fund and includes participation AJAX Strategies and other individual investors.

The company plans to use the funds to build out its research and development, engineering, supply chain, and production teams.

"Infinitum's mission aligns well with our goals for the Future Energy Fund," says Barbara Burger, president of CTV, in a release. "The purpose of the Future Energy Fund is to invest in breakthrough energy technologies that reflect Chevron's commitment to lower emission energy sources and that are integral to low-carbon and efficient value chains."

4 Houston researchers named fellows of the National Academy of Inventors

ideas

Getty Images

The National Academy of Inventors named 168 academic innovators to NAI Fellow status — and four conduct their research right here in Houston. The program "highlights academic inventors who have demonstrated a spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on quality of life, economic development and the welfare of society," reads the news release.

The four Houston inventors and their institutions are as follows:

List ranks Houston's fastest growing companies

Chart via Grojo.com

Growjo named the 100 fastest-growing companies in Houston for 2019, and, while the study notes the city's large oil and gas and medical industries, also acknowledges its growing tech and software scene. The companies were selected by a myriad of factors.

"Our algorithm is based on multiple datasets including employee growth, estimated revenue growth, valuations, quality and quantity of funding, hiring announcements, current job openings, leadership team announcements, and numerous other growth triggers," reads the website.

The top five companies on the list are:

  1. Midcoast Energy, which has 183 employees and a 17 percent employee growth rate.
  2. ibüümerang, which has 528 employees, and a 633 percent employee growth rate.
  3. Arion, which has 136 employees and a 216 percent employee growth rate.
  4. GoExpedi, which as 59 employees and a 119 percent employee growth rate.
  5. Code Ninjas, which has 338 employees and a 63 percent employee growth rate.

For the full list, visit Growjo.com.

TMCx company wins awards 

Image via abilitechmedical.com

Abilitech Medical, which recently completed the TMCx program, has taken home some wins in Minnesota, where it's based. The company was named named among the state's topmed tech companies by the Minnesota High Tech Association at the 2019 TEKNE awards and 2019, as well as the grand prize winner and top woman-led business by the University of Minnesota's business school at its 2019 Minnesota Cup competition.

The medical device company's technology includes the Abilitech™ Assist, which assists patients with Multiple Sclerosis, rehabilitating from stoke, or other conditions with eating, drinking, and using a computer.

"We've met so many people whose lives will be changed with this innovation," says CEO and founder Angie Conley in a news release. "Through the Texas Medical Center accelerator, we met Dr. Hany Samir who championed our upcoming stroke study."

Samir is a cardiac anesthesiologist at Houston Methodist. He lost his ability to work and perform simple daily functions after a stroke debilitated his left arm.

"I'm unable to practice the medicine I love. I want to hold my wife again with two hands and enjoy dinner with her, without having her cut my food. I want to have a cup of coffee without asking for help," says Samir in the release. "Regaining function in my arm will restore my life."

Pandata Tech receives Department of Defense contract

Photo courtesy of Pandata Tech

Houston-based ​Pandata Tech secured a contract with the United States Department of Defense from the Rapid Sustainment Office of the the United States Air Force last month. The Phase II contract will allow the company to work with Joint Base Elmendorf-Richardson in Alaska to develop a scalable data quality platform.

The access to data will aid in natural disasters, per the release. The goal of the contract would be for a Phase III contract and an opportunity to scale the technology into other branches of military. The company also had a Phase I contract signed in August before securing the Phase II in November.

"Pandata Tech's proprietary DQM software was built during a development partnership with one of the world's largest offshore drilling companies. Because the technology was tested and built with offshore drilling data, the shift to aircraft carriers would be smooth," explains Gustavo Sanchez, co-founder of Pandata Tech, in a news release.

Houston company receives Department of Energy funding

Photo via aerominepower.com

The U.S. Department of Energy's National Renewable Energy Laboratory — with funding from the DOE's Office of Energy Efficiency and Renewable Energy Wind Energy Technologies Office — selected a Houston company for its Competitiveness Improvement Project.

Westergaard Solutions, founded by Houstonian Carsten Westergaard, was named among the 2019 CIP Awardees. Among the company's assets is AeroMine, which competed in the most recent Houston cohort in MassChallenge Texas. The company "will implement an innovative building-integrated wind generation concept with no external moving parts, moving from a preliminary conceptual design to a pre-production prototype design that is ready for testing," according to the release.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Rice Alliance and the Ion leader Brad Burke to retire this summer

lasting legacy

Brad Burke—a Rice University associate vice president who leads the Ion District’s Rice Alliance for Technology and Entrepreneurship and is a prominent figure in Houston’s startup community—is retiring this summer after a 25-year career at the university.

Burke will remain at the Rice Alliance as an adviser until his retirement on June 30.

“Brad’s impact on Rice extends far beyond any single program or initiative. He grew the Rice Alliance from a promising campus initiative into one of the most respected university-based entrepreneurship platforms,” Rice President Reginald DesRoches said in a news release.

During Burke’s tenure, the Rice Business School went from unranked in entrepreneurship to The Princeton Review’s No. 1 graduate entrepreneurship program for the past seven years and a top 20 entrepreneurship program in U.S. News & World Report’s rankings for the past 14 years.

“Brad didn’t just build programs — he built an ecosystem, a culture, and a reputation for Rice that now resonates around the world,” said Peter Rodriguez, dean of the business school. “Through his vision and steady leadership, Rice became a place where founders are taken seriously, ideas are rigorously supported, and entrepreneurship is embedded in the fabric of the university.”

One of Burke’s notable achievements at Rice is the creation of the Rice Business Plan Competition. During his tenure, the competition has grown from nine student teams competing for $10,000 into the world’s largest intercollegiate competition for student-led startups. Today, the annual competition welcomes 42 student-led startups that vie for more than $1 million in prizes.

Away from Rice, Burke has played a key role in cultivating entrepreneurship in the energy sector: He helped establish the Energy Tech Venture Forum along with Houston Energy and Climate Startup Week.

Furthermore, Burke co-founded the Texas University Network for Innovation and Entrepreneurship in 2008 to bolster the entrepreneurship programs at every university in Texas. In 2016, the Rice Alliance assumed leadership of the Global Consortium of Entrepreneurship Centers.

In 2023, Burke received the Trailblazer Award at the 2023 Houston Innovation Awards and was recognized by the Deshpande Foundation for his contributions to innovation and entrepreneurship in higher education.

“Working with an amazing team to build the entrepreneurial ecosystem at Rice, in Houston, and beyond has been the privilege of my career,” Burke said in the release. “It has been extremely gratifying to hear entrepreneurs say our efforts changed their lives, while bringing new innovations to market. The organization is well-positioned to help drive exponential growth across startups, investors, and the entrepreneurial ecosystem.”

Starting April 15, John “JR” Reale Jr. will serve as interim associate vice president at Rice and executive director of the Rice Alliance. He is managing director of the alliance and co-founder of Station Houston, beginning April 15. Reale is co-founder of the Station Houston startup hub and a startup investor and was also recently named director for startups and investor engagement for the Ion.

“The Rice Alliance has always been about helping founders gain advantages to realize their visions,” Reale said. “Under Brad’s leadership, the Rice Alliance has become a globally recognized platform that is grounded in trust and drives transformational founder outcomes. My commitment is to honor what Brad has built and led while continuing to serve our team and community, deepen relationships and deliver impact.”

Burke joined the Houston Innovators Podcast back in 2022. Listen to the full interview here.

Houston team uses CPRIT funding to develop nanodrug for cancer immunotherapy

cancer research

With a relative five-year survival rate of 50 percent, pancreatic cancer is a diagnosis nobody wants. At 60 percent, the prognosis for lung cancer isn’t much rosier. That’s because both cancers contain regulatory B cells (Bregs), which block the body’s natural immunity, making it harder to fight the enemies within.

Newly popular immunotherapies in a category known as STING agonists may stimulate natural cancer defenses. However, they can also increase Bregs while simultaneously causing significant side effects. But Wei Gao, assistant professor of pharmacology at the University of Houston College of Pharmacy, may have a solution to that conundrum.

Gao and her team have developed Nano-273, a dual-function drug, packaged in an albumin-based particle, that boosts the immune system to help it better fight pancreatic and lung cancers. Gao’s lab recently received a $900,000 grant from the Cancer Prevention and Research Institute of Texas (CPRIT) to aid in fueling her research into the nanodrug.

“Nano-273 both activates STING and blocks PI3Kγ—a pathway that drives Breg expansion, while albumin nanoparticles help deliver the drug directly to immune cells, reducing unwanted side effects,” Gao said in a press release. “This approach reduces harmful Bregs while boosting immune cells that attack cancer, leading to stronger and more targeted anti-tumor responses.”

In studies using models of both pancreatic and lung cancers, Nano-273 has shown great promise with low toxicity. Its best results thus far have involved using the drug in combination with immunotherapy or chemotherapy.

With the CPRIT funds, Gao and her team will be able to charge closer to clinical use with a series of important steps. Those include continuing to test Nano-273 alongside other drugs, including immune checkpoint inhibitors. Safety studies will follow, but with future patients in mind, Gao will also work toward improving her drug’s production, making sure that it’s safe and high-quality every time, so that it is eventually ready for trials.

Gao added: “If successful, this project could lead to a new type of immunotherapy that offers lasting tumor control and improved survival for patients with pancreatic and lung cancers, two diseases that urgently need better treatments."

Houston booms as No. 2 U.S. metro for new home construction

Construction Boom

Driven by population growth, more residential rooftops are popping up across Houston and the rest of Texas than anywhere else in America.

Using data from the U.S. Census Bureau and Zillow, Construction Coverage found 65,747 new residential units were authorized in greater Houston in 2024. That figure landed Houston in second place among major metro areas for the total number of housing permits, including those for single-family homes, apartments, and condos.

Just ahead of Houston was the Dallas-Fort Worth Metroplex, which took first place with 71,788 residential permits approved in 2024. In third place was the country’s largest metro, New York City (57,929 permits).Elsewhere in Texas, the Austin metro ranked sixth (32,294 permits), and the San Antonio metro ranked 20th (14,857 permits).

Construction Coverage also sorted major metro areas based on the number of new housing units authorized per 1,000 existing homes in 2024. Raleigh, North Carolina, held the No. 1 spot (28.8 permits per 1,000 existing homes), followed by Austin at No. 2 (28.6), DFW at No. 3 (22.2), Houston at No. 4 (21.6), and San Antonio at No. 13 (13.6).

A Newsweek analysis of Census Bureau data shows building permits for 225,756 new residential units were approved in 2024 in Texas — a trend fueled largely by activity in DFW, Houston, Austin, and San Antonio. That put Texas atop the list of states building the most residential units for the year.

Through the first eight months of last year, 145,901 permits for new residential units were approved in Texas, according to Census Bureau data. That’s nearly 80,000 permits shy of the 2024 total.

Among the states, Construction Coverage ranks Texas sixth for the number of residential building permits approved in 2024 per 1,000 existing homes (17.9).

Extra housing is being built in Texas to meet demand spurred by population growth. From April 2020 to July 2024, the state’s population increased 7.3 percent, the Census Bureau says.

While builders are busy constructing new housing in Texas, they’re not necessarily profiting a lot from homebuilding activity.

“Market conditions remain challenging, with two-thirds of builders reporting they are offering incentives to move buyers off the fence,” North Carolina homebuilder Buddy Hughes, chairman of the National Association of Home Builders, said in a December news release. “Meanwhile, builders are contending with rising material and labor prices, as tariffs are having serious repercussions on construction costs.”